Skip to main content
PMC home page
Springer logoLink to Springer
. 2021 Nov 8;61(3):1285–1297. doi: 10.1007/s00394-021-02734-6

Association of dairy intake with all-cause, cancer, and cardiovascular disease mortality in Japanese adults: a 25-year population-based cohort

Yukai Lu 1, Yumi Sugawara 1,✉, Sanae Matsuyama 1, Akira Fukao 2, Ichiro Tsuji 1
PMCID: PMC8921048  PMID: 34750640

Abstract

Purpose

The association between dairy intake and mortality remains uncertain, and evidence for the Japanese population is scarce. We aimed to investigate the association between dairy intake and all-cause, cancer, and cardiovascular disease (CVD) mortality in Japanese adults.

Methods

A total of 34,161 participants (16,565 men and 17,596 women) aged 40–64 years without a history of cancer, myocardial infarction, or stroke at baseline were included in the analysis, using data from the Miyagi Cohort Study initiated in 1990. Milk, yogurt, and cheese intake were obtained using a validated food frequency questionnaire. Total dairy intake was calculated as the sum of milk, yogurt, and cheese intake and then categorized by quartile. The outcomes were all-cause, cancer, and CVD mortality. Cox proportional hazards regression models were used to estimate multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality risks.

Results

During 750,016 person-years of follow-up, the total number of deaths was 6498, including 2552 deaths due to cancer and 1693 deaths due to CVD. There was no association between total dairy intake and all-cause, cancer, and CVD mortality for both men and women. We also examined the associations between subgroup dairy products and mortality. For milk and yogurt intake, our results suggest null associations. However, cheese intake was modestly associated with lower all-cause mortality in women; compared with non-consumers, the multivariable HRs (95%CIs) were 0.89 (0.81–0.98) for 1–2 times/month, 0.88 (0.78–1.00) for 1–2 times/week, and 0.89 (0.74–1.07) for 3 times/week or almost daily (p trend = 0.016).

Conclusion

Dairy intake was not associated with mortality in Japanese adults, except for limited evidence showing a modest association between cheese intake and a lower all-cause mortality risk in women.

Supplementary Information

The online version contains supplementary material available at 10.1007/s00394-021-02734-6.

Keywords: Dairy, Milk, Yogurt, Cheese, Cancer, Cardiovascular disease, Mortality

Introduction

Dairy products contribute various valuable nutrients to the overall diet, including protein, vitamins, and minerals, and consumption of dairy products is recommended in most dietary guidelines worldwide [1]. Previous studies have suggested that associations between dairy intake and multiple health outcomes, including diabetes mellitus [2], cardiovascular diseases (CVD) [3], breast cancer [4, 5], and colorectal cancer [5, 6], are null or weak inverse. Minerals in milk such as calcium, potassium, and magnesium may have played a role in the effect of milk on reducing blood pressure, which then may contribute to lowering the risk of CVDs [7]. However, recent randomized controlled trials have shown dairy-rich diet has no effect on blood pressure compared to dairy-free diet [8, 9]. Also, dairy products have a high content of saturated fat which raises low-density lipoprotein cholesterol level, consequently contributing to higher risk of CVDs [10], but current evidence has shown that neither whole milk nor low-fat milk has been clearly associated with CVDs [11]. Moreover, calcium in milk is related to protecting against the breast cancer and colorectal cancer risks [5].

However, it is possible that high consumption of dairy foods is associated with increased risks of prostate cancer [5, 12]. Greater concentrations of insulin-like growth factor I (IGF-I) has been associated with the elevated prostate cancer risk, and milk consumption may increase IGF-I blood concentrations [13]. Evidence also has showed that total dairy intake is associated with a higher risk of endometrial cancer, particularly among postmenopausal women who are not currently using hormone therapy [14], which may attribute to the sex-hormone content of dairy products such as estrogen [15]. Therefore, whether dairy intake is beneficial or harmful to health is controversial due to the various nutrients in dairy products.

Numerous meta-analyses have investigated the association between dairy intake and mortality, but their results have been controversial [16–24]. Some suggested that higher dairy intake was associated with a lower mortality risk [16, 23], whereas others suggested a null association [17–19, 21, 22, 24]. Larsson et al. argued that it was perhaps inappropriate to pool the results due to their considerable heterogeneity [20]. It should be mentioned that most studies are conducted in Europe or North America where dairy products are traditionally consumed far more than in other regions [16]. Several cohort studies from Japan examining dairy intake and mortality showed inconsistent results [25–27]. One study found that milk drinking was associated with a lower risk of CVD mortality and cancer mortality in men [27], but the other two suggested null associations [25, 26]. Thus, whether different patterns of dairy intake between Western and Asian populations may be associated with mortality differently has been unclear. It also needs to be noted that different kinds of dairy products vary in their nutrient composition, so they may have different effects on health [16]. For example, previous studies suggested that yogurt or cheese rather than milk intake was associated with a lower risk of all-cause mortality [16, 28, 29].

Thus, the aim of the present study was to examine the association of dairy intake with all-cause, cancer, and CVD mortality in Japanese adults, using a large-scale population-based cohort with follow-up over 25 years.

Materials and methods

Study participants

The data used in the present study came from the Miyagi Cohort, the design of which has been described in detail elsewhere [30, 31]. In brief, between June and August 1990, a self-administered questionnaire on various health conditions was delivered to all residents aged 40–64 years (n = 51,921) in 14 municipalities of Miyagi Prefecture, northeastern Japan. Of them, 47,605 were confirmed to be eligible (response rate: 91.7%) (Fig. 1).

Fig. 1.

Fig. 1

Open in a new tab

Flowchart of study participants

For the present analysis, one participant withdrawn from the study before follow-up starting, 2137 participants who had a history of cancer, myocardial infarction, or stroke at baseline, and 11,306 persons who did not answer the questions on milk, yogurt, or cheese intake were excluded. Eventually, 34,161 responses (16,565 men and 17,596 women) were included for the present analysis.

The study protocol was approved by the institutional review board of the Tohoku University School of Medicine (Approval No. 2014–1-838). We considered the return of self-administered questionnaires signed by the participants to imply their consent to participate in the study.

Dietary assessment and dairy intake (exposure)

Participants were asked about the average intake of dairy products including milk, yogurt, and cheese, as well as other food items, during the previous year, using a validated food frequency questionnaire (FFQ). The FFQ included 39 food items and several beverages. For dairy products intake, participants were required to choose from the following five categories: “almost never”, “1–2 times/month”, “1–2 times/week”, “3–4 times/week”, and “almost daily”.

We also conducted a validation study for the FFQ we used for this study previously [32]. The age- and total energy-adjusted Spearman’s correlation coefficients between 3-day diet records and the FFQ were 0.72 for milk, 0.56 for yogurt, and 0.36 for cheese in men, and 0.65 for milk, 0.60 for yogurt, and 0.36 for cheese in women.

The volume of each food intake was calculated by converting the intake frequency from the FFQ into a daily intake volume (g/day). Daily intake was calculated by multiplying the average number of daily servings (times/day) by an assigned portion size (g/time) from the FFQ based on the median values observed in the validation study. Total dairy intake was calculated as the sum of daily intake of milk, yogurt, and cheese and was then sex-specifically categorized by quartile, with Q1 the lowest quartile and Q4 the highest one. For estimation of energy and other nutrient intakes from the food intake volume based on the FFQ, a food composition table that corresponded to the items listed in the questionnaire was used. This food composition table was developed using the Standard Tables of Food Composition published by the Science and Technology Agency of Japan [33].

Follow-up

The primary outcomes were all-cause, cancer, and CVD mortality, and the secondary outcomes were coronary heart disease (CHD) and stroke morality as well as lung cancer, gastric cancer, and colorectal cancer mortality. To follow-up the participants for mortality and migration, we established a Follow-up Committee [30, 34, 35], consisting of the Miyagi Cancer Society, the Community Health Divisions of all 14 municipalities, the Department of Health and Welfare of Miyagi Prefectural Government, and the Division of Epidemiology, Tohoku University Graduate School of Medicine. The Committee periodically reviewed the Residential Registration Record of each municipality. With this review, we identified participants who had either died or emigrated during the follow-up period. We discontinued follow-up with those who had emigrated from the study area, because the Committee could not review the Residential Registration Record from outside the study area.

For identified decedents, we further investigated cause of death by reviewing the death certificates of the participants at Public Health Centres in the study area. The cause of death was defined according to the International Classification of Diseases (ICD) 9th revision (ICD-9) between June 1, 1990 and December 31, 1998 and the 10th revision (ICD-10) between January 1, 1999 and March 31, 2015. Death due to CVD was coded by ICD-9:390-459 or ICD-10:I00-I99 (CHD: ICD-9:410-414 or ICD-10:I20-I25; stroke:ICD-9:430-438 or ICD-10:I60-I69), and death due to cancer was coded by ICD-9:140–239 or ICD-10:C00-D09 (lung cancer:ICD-9:162 or ICD-10:C34; gastric cancer:ICD-9:151 or ICD-10:C16; colorectal cancer:ICD-9:153-154 or ICD-10:C18-C20).

Participants were followed up from June 1, 1990 to March 31, 2015. The number of person-years of follow-up for each participant was counted from the beginning of follow-up until the date of death, the date of emigration from the study districts, or the end of follow-up, whichever occurred first. During the follow-up period, 2997 participants (8.8%) were lost to follow-up.

Statistical analysis

Cox proportional hazards model was used to calculate the sex-specific hazard ratios (HRs) and 95% confidence intervals (95% CIs) for mortality according to the quartile of total dairy intake, with participants in the lowest quartile (Q1) as the reference. Dummy variables were created for each group of exposure and categorical covariates. Missing values of each covariate were classified into an extra group. Time of follow-up was used as the time scale. Multivariable models were adjusted as follows: Model 1 was adjusted for age (continuous); Model 2 was further adjusted for education level (junior high school or lower, high school, college or higher, or missing), BMI (< 18.5 kg/m2, 18.5–24.9 kg/m2, ≥ 25.0 kg/m2, or missing), smoking status (never, former, < 20 cigarettes/day, ≥ 20 cigarettes/day, or missing), alcohol drinking status (never, former, current, or missing), and history of disease [hypertension and diabetes mellitus (yes or no for each)]; Model 3 was further adjusted for energy intake (in tertiles, or missing), vegetable and fruit intake (in tertiles, or missing), and fish intake (in tertiles, or missing). In addition, a test for trend was also conducted by coding the exposure variable using the median value of each category in the models.

A sensitivity analysis was also conducted by excluding deaths in the initial three years of follow-up, considering the possible reverse causality where health condition at baseline may affect dairy intake. Then, several stratified analyses according to age (< 50 vs. ≥ 50 y), BMI (< 25.0 vs. ≥ 25.0 kg/m2), and smoking status (current vs. non-current) were also conducted, because these covariates which have a great impact on health outcomes may differ the association between dairy intake and mortality. A test for interaction was also performed by adding an additional cross-product term of exposure variable and stratified covariate to the models. Because 11,306 persons with missing data on milk, yogurt, or cheese were excluded from the present analysis, which may affect the results, multiple imputations for missing data on dairy products were also applied. Five datasets with missing values being imputed according to age, sex, and other covariates, and Cox models were then created and applied to calculate the pooled HRs and 95% CIs for mortality using the five imputed datasets [36].

Milk, yogurt, and cheese intake frequency were categorized into four groups based on FFQ responses. To obtain sufficient participants in each group, we combined “almost never” and “1–2 times/month” for milk, and “3–4 times/week” and “almost daily” for yogurt and cheese. Butter was not included because it is distinct from other dairy foods in nutritional components and its correlation between 3-day diet records and the FFQ (0.20 for men and 0.11 for women) was much lower than other dairy products. All analyses were repeated using each dairy product intake frequency as the exposure variable, with the least frequent group as the reference.

All analyses were performed using SAS version 9.4 (SAS Inc., Cary, NC, USA). All statistical tests described were two-sided, and differences at p < 0.05 were considered statistically significant.

Results

Baseline characteristics

During 750,016 person-years of follow-up, the total number of deaths was 6876 (4354 men and 2522 women), including 2552 deaths due to cancer (1713 men and 839 women) and 1693 deaths due to CVD (1048 men and 645 women). Table 1 shows the baseline characteristics by total dairy intake. The mean (standard deviation) total dairy intake was 125.9 (93.9) g/day for men and 148.1 (94.9) g/day for women, which was similar to that of general Japanese population (mean 130.1 g/day) [37] but was less than half of the amount in western countries measured in previous studies [38–42]. In both men and women, people with higher dairy intake were more likely to have a high education level, to be never smokers, to have high energy intake, or to have high vegetable and fruit intake.

Table 1.

Characteristics at baseline according to total dairy intake (n = 34,161)

Quartile of total dairy intakeβ
Q1 Q2 Q3 Q4
Men (n = 16,565)
 No. of participants 3979 4195 3366 5025
 Dairy intake (g/day)α 6.6 (7.5) 71.5 (27.7) 180.0 (41.8) 229.7 (26.7)
 Range of quartiles (g/day) 0–40.8 44.9–109.8 110.8–210.0 211.0–325.0
 Age (years)α 50.1 (7.4) 49.7 (7.3) 51.2 (7.5) 50.7 (7.4)
 College or higher (%)β 12.6 14.8 16.1 19.3
 BMI (kg/m2)α 23.5 (2.8) 23.7 (2.8) 23.7 (2.8) 23.5 (2.6)
 Never smokers (%) 14.8 18.0 20.1 23.3
 Never alcohol drinkers (%) 14.3 13.6 15.9 16.6
 Time spent walking (> 1 h/day) (%) 44.5 42.2 44.5 42.5
 Energy intake (kJ/day)α 7126.9 (2545.4) 7496.3 (2443.0) 7742.4 (2386.4) 8050.9 (2376.2)
 Fish intake (g/day)α 56.7 (35.3) 58.7 (33.5) 63.3 (34.7) 63.0 (34.2)
 Vegetable and fruit intake (g/day)α 146.8 (101.1) 165.8 (100.9) 188.4 (110.0) 216.9 (112.9)
 History of hypertension (%) 17.1 17.5 17.2 16.8
 History of diabetes (%) 3.5 4.2 6.5 5.9
Women (n = 17,596)
 No. of participants 4396 4135 4514 4551
 Dairy intake (g/day)α 17.5 (19.0) 103.8 (32.1) 212.9 (2.6) 250.1 (27.0)
 Range of quartiles (g/day) 0–49.4 49.9–205.0 210.0–224.5 229.3–310.0
 Age (years)α 51.1 (7.4) 49.8 (7.1) 52.2 (7.2) 50.6 (7.3)
 College or higher (%)β 9.6 13.8 14.4 19.1
 BMI (kg/m2)α 23.8 (3.3) 23.6 (3.1) 23.7 (3.0) 23.5 (3.0)
 Never smokers (%) 86.3 89.8 90.7 92.2
 Never alcohol drinkers (%) 69.6 69.3 71.6 68.9
 Time spent walking (> 1 h/day) (%) 44.0 44.2 45.1 42.2
 Energy intake (kJ/day)α 5108.0 (1390.5) 5528.2 (1321.6) 5819.0 (1353.1) 6050.7 (1292.3)
 Fish intake (g/day)α 49.6 (29.5) 53.8 (28.6) 56.3 (29.2) 59.1 (28.7)
 Vegetable and fruit intake (g/day)α 213.7 (116.9) 246.4 (111.4) 252.5 (112.8) 291.7 (112.9)
 History of hypertension (%) 20.8 17.1 19.1 17.8
 History of diabetes (%) 2.2 1.8 3.8 3.1
Open in a new tab

αMean (standard deviation) for all such values

βAged ≥ 19 y when participants had completed their education

Dairy intake and mortality

The sex-specific associations between total dairy intake and all-cause, cancer, and CVD mortality are presented in Table 2. However, there were no associations between total dairy intake and all-cause, cancer, and CVD mortality in both men and women. Tables 3, 4 and 5 show the associations between milk, yogurt, and cheese intakes and mortality, respectively. Similarly, our results suggest null associations between milk or yogurt intake and all-cause, cancer, and CVD mortality in both men and women (Tables 3, 4). However, for cheese intake (Table 5), a modest association with a lower risk of all-cause mortality was observed in women; compared with non-consumers, the multivariable HRs (95%CI) were 0.89 (0.81–0.98) for 1–2 times/month, 0.88 (0.78–1.00) for 1–2 times/week, and 0.89 (0.74–1.07) for 3 times/week or almost daily (p trend = 0.016). We also examined the association between dairy intake and secondary outcomes including CHD and stroke mortality, as well as lung cancer, gastric cancer, and colorectal cancer mortality, but no association was found (e-Tables 1&2).

Table 2.

Association between total dairy intake and mortality (n = 34,161)α

Quartile of total dairy intakeβ P trendγ
Q1 Q2 Q3 Q4
Men
 Person-years 84,007 89,576 71,387 1,08,493
All-cause mortality
 No. of death 1102 1023 956 1273
 Model 1δ 1.00 (ref.) 0.91 (0.84–0.99) 0.95 (0.87–1.03) 0.84 (0.78–0.92) 0.003
 Model 2ε 1.00 (ref.) 0.94 (0.86–1.02) 0.98 (0.90–1.07) 0.91 (0.84–0.99) 0.174
 Model 3ζ 1.00 (ref.) 0.94 (0.87–1.03) 0.98 (0.90–1.07) 0.93 (0.85–1.01) 0.328
Cancer mortality
 No. of death 437 421 363 492
 Model 1δ 1.00 (ref.) 0.95 (0.83–1.08) 0.91 (0.79–1.04) 0.83 (0.73–0.94) 0.006
 Model 2ε 1.00 (ref.) 0.98 (0.85–1.12) 0.95 (0.82–1.09) 0.90 (0.79–1.02) 0.121
 Model 3ζ 1.00 (ref.) 0.99 (0.86–1.13) 0.96 (0.83–1.10) 0.92 (0.81–1.05) 0.237
CVD mortality
 No. of death 268 232 236 312
 Model 1δ 1.00 (ref.) 0.86 (0.72–1.02) 0.96 (0.80–1.14) 0.85 (0.72–1.00) 0.339
 Model 2ε 1.00 (ref.) 0.88 (0.74–1.05) 0.99 (0.83–1.18) 0.93 (0.79–1.10) 0.978
 Model 3ζ 1.00 (ref.) 0.88 (0.74–1.05) 0.99 (0.83–1.18) 0.94 (0.79–1.11) 0.972
Women
 Person-years 98,927 93,883 1,01,276 1,02,466
All-cause mortality
 No. of death 659 518 731 614
 Model 1δ 1.00 (ref.) 0.93 (0.83–1.05) 1.00 (0.90–1.11) 0.94 (0.84–1.05) 0.644
 Model 2ε 1.00 (ref.) 0.97 (0.87–1.09) 1.04 (0.94–1.16) 0.98 (0.88–1.10) 0.722
 Model 3ζ 1.00 (ref.) 0.98 (0.87–1.10) 1.05 (0.94–1.17) 1.00 (0.89–1.12) 0.574
Cancer mortality
 No. of death 228 161 235 215
 Model 1δ 1.00 (ref.) 0.82 (0.67–1.01) 0.94 (0.79–1.13) 0.94 (0.78–1.14) 0.723
 Model 2ε 1.00 (ref.) 0.85 (0.69–1.04) 0.97 (0.80–1.16) 0.98 (0.81–1.18) 0.970
 Model 3ζ 1.00 (ref.) 0.85 (0.69–1.04) 0.98 (0.81–1.17) 0.99 (0.82–1.21) 0.899
CVD mortality
 No. of death 170 133 192 150
 Model 1δ 1.00 (ref.) 0.96 (0.77–1.21) 1.00 (0.81–1.23) 0.90 (0.72–1.12) 0.586
 Model 2ε 1.00 (ref.) 1.01 (0.81–1.27) 1.05 (0.86–1.30) 0.94 (0.75–1.17) 0.917
 Model 3ζ 1.00 (ref.) 1.03 (0.82–1.30) 1.06 (0.86–1.31) 0.95 (0.76–1.20) 0.976
Open in a new tab

αHazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated by Cox proportional hazards models

βRanges for the quartiles of total dairy intake were 0–40.8 g/day, 44.9–109.8 g/day, 110.8–210.0 g/day, and 211.0–325.0 g/day in men and 0–49.4 g/day, 49.9–205.0 g/day, 210.0–224.5 g/day, and 229.3–310.0 g/day in women

γP trend was calculated using the median value of each category of total dairy intake

δModel 1 was adjusted for age (continuous)

εModel 2 was adjusted for Model 1 plus education level (junior high school or lower, high school, college or higher, or missing), BMI (< 18.5 kg/m2, 18.5–24.9 kg/m2, ≥ 25.0 kg/m2, or missing), smoking status (never, former, < 20 cigarettes/day, ≥ 20 cigarettes/day, or missing), alcohol drinking status (current, never, former, or missing), history of hypertension (yes, or no), and history of diabetes (yes, or no)

ζModel 3 was adjusted for Model 2 plus energy intake (sex-specific tertiles or missing), fish intake (sex-specific tertiles or missing),and vegetable and fruit intake (sex-specific tertiles or missing)

Table 3.

Association between milk intake and mortality (n = 34,161)α

Milk intake frequency P trendβ
Almost never/1–2 times/mo 1–2 times/week 3–4 times/week Almost daily
Men
 Person-years 86,587 55,599 57,796 1,53,481
All-cause mortality
 No. of death 1131 635 632 1956
 Model 1γ 1.00 (ref.) 0.94 (0.85–1.04) 0.88 (0.80–0.97) 0.90 (0.84–0.97) 0.004
 Model 2δ 1.00 (ref.) 0.96 (0.87–1.06) 0.92 (0.83–1.01) 0.95 (0.88–1.02) 0.184
 Model 3ε 1.00 (ref.) 0.97 (0.88–1.06) 0.93 (0.84–1.02) 0.96 (0.89–1.04) 0.339
Cancer mortality
 No. of death 451 255 274 733
 Model 1γ 1.00 (ref.) 0.95 (0.81–1.11) 0.95 (0.82–1.11) 0.85 (0.75–0.95) 0.005
 Model 2δ 1.00 (ref.) 0.97 (0.83–1.13) 1.00 (0.86–1.16) 0.91 (0.80–1.02) 0.107
 Model 3ε 1.00 (ref.) 0.98 (0.84–1.14) 1.01 (0.87–1.18) 0.93 (0.82–1.04) 0.214
CVD mortality
 No. of death 271 139 150 488
 Model 1γ 1.00 (ref.) 0.86 (0.71–1.06) 0.87 (0.72–1.07) 0.93 (0.80–1.08) 0.504
 Model 2δ 1.00 (ref.) 0.89 (0.72–1.09) 0.92 (0.75–1.12) 1.00 (0.86–1.16) 0.794
 Model 3ε 1.00 (ref.) 0.89 (0.72–1.09) 0.92 (0.76–1.13) 1.00 (0.86–1.17) 0.787
Women
 Person-years 77,460 51,494 63,856 2,03,743
All-cause mortality
 No. of death 527 295 355 1345
 Model 1γ 1.00 (ref.) 0.99 (0.86–1.14) 0.92 (0.80–1.05) 0.97 (0.88–1.08) 0.572
 Model 2δ 1.00 (ref.) 1.00 (0.87–1.16) 0.96 (0.84–1.10) 1.01 (0.92–1.12) 0.785
 Model 3ε 1.00 (ref.) 1.00 (0.87–1.16) 0.97 (0.84–1.11) 1.02 (0.92–1.14) 0.633
Cancer mortality
 No. of death 183 96 110 450
 Model 1γ 1.00 (ref.) 0.90 (0.70–1.15) 0.80 (0.63–1.02) 0.94 (0.79–1.11) 0.574
 Model 2δ 1.00 (ref.) 0.91 (0.71–1.17) 0.83 (0.65–1.05) 0.96 (0.81–1.15) 0.822
 Model 3ε 1.00 (ref.) 0.92 (0.72–1.18) 0.84 (0.66–1.06) 0.98 (0.82–1.17) 0.950
CVD mortality
 No. of death 132 78 93 342
 Model 1γ 1.00 (ref.) 1.09 (0.82–1.44) 0.99 (0.76–1.29) 0.99 (0.81–1.21) 0.732
 Model 2δ 1.00 (ref.) 1.10 (0.83–1.46) 1.06 (0.81–1.38) 1.04 (0.84–1.27) 0.888
 Model 3ε 1.00 (ref.) 1.11 (0.84–1.47) 1.08 (0.82–1.41) 1.05 (0.85–1.30) 0.771
Open in a new tab

αHazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated by Cox proportional hazards models

βP trend was calculated by treating exposure as a continuous variable

γModel 1 was adjusted for age (continuous)

δModel 2 was adjusted for Model 1 plus education level (junior high school or lower, high school, college or higher, or missing), BMI (< 18.5 kg/m2, 18.5–24.9 kg/m2, ≥ 25.0 kg/m2, or missing), smoking status (never, former, < 20 cigarettes/day, ≥ 20 cigarettes/day, or missing), alcohol drinking status (current, never, former, or missing), history of hypertension (yes, or no), and history of diabetes (yes, or no)

εModel 3 was adjusted for Model 2 plus energy intake (sex-specific tertiles or missing), protein intake (sex-specific tertiles or missing), fish intake (sex-specific tertiles or missing),and vegetable and fruit intake (sex-specific tertiles or missing)

Table 4.

Association between yogurt intake and mortality (n = 34,161)α

Yogurt intake frequency P trendβ
Almost never 1–2 times/mo 1–2 times/wk 3 times/week/
Almost daily
Men
 Person-years 2,02,265 82,965 43,393 24,840
All-cause mortality
 No. of death 2680 883 458 333
 Model 1γ 1.00 (ref.) 0.85 (0.79–0.92) 0.83 (0.75–0.92) 0.95 (0.85–1.07) 0.001
 Model 2δ 1.00 (ref.) 0.90 (0.83–0.97) 0.88 (0.80–0.97) 1.02 (0.91–1.14) 0.111
 Model 3ε 1.00 (ref.) 0.91 (0.84–0.98) 0.90 (0.81–0.99) 1.04 (0.92–1.17) 0.253
Cancer mortality
 No. of death 1048 348 191 126
 Model 1γ 1.00 (ref.) 0.86 (0.76–0.97) 0.89 (0.76–1.04) 0.92 (0.77–1.11) 0.064
 Model 2δ 1.00 (ref.) 0.90 (0.79–1.01) 0.95 (0.81–1.11) 1.00 (0.83–1.20) 0.473
 Model 3ε 1.00 (ref.) 0.91 (0.80–1.03) 0.97 (0.83–1.14) 1.03 (0.85–1.24) 0.791
CVD mortality
 No. of death 647 213 112 76
 Model 1γ 1.00 (ref.) 0.86 (0.73–1.00) 0.85 (0.69–1.04) 0.90 (0.71–1.14) 0.064
 Model 2δ 1.00 (ref.) 0.92 (0.79–1.08) 0.91 (0.74–1.11) 0.99 (0.78–1.25) 0.448
 Model 3ε 1.00 (ref.) 0.93 (0.80–1.09) 0.91 (0.75–1.12) 0.99 (0.78–1.26) 0.488
Women
 Person-years 1,30,658 1,06,634 94,770 64,491
All-cause mortality
 No. of death 987 612 538 385
 Model 1γ 1.00 (ref.) 0.89 (0.80–0.98) 0.91 (0.82–1.01) 0.88 (0.78–0.99) 0.027
 Model 2δ 1.00 (ref.) 0.91 (0.82–1.01) 0.94 (0.84–1.04) 0.91 (0.81–1.03) 0.109
 Model 3ε 1.00 (ref.) 0.91 (0.83–1.01) 0.94 (0.85–1.05) 0.92 (0.81–1.03) 0.146
Cancer mortality
 No. of death 307 209 177 146
 Model 1γ 1.00 (ref.) 0.95 (0.80–1.13) 0.94 (0.78–1.13) 1.06 (0.87–1.29) 0.825
 Model 2δ 1.00 (ref.) 0.97 80.82–1.16) 0.96 (0.80–1.16) 1.08 (0.88–1.32) 0.641
 Model 3ε 1.00 (ref.) 0.98 (0.82–1.17) 0.97 (0.81–1.18) 1.10 (0.89–1.34) 0.541
CVD mortality
 No. of death 262 157 131 95
 Model 1γ 1.00 (ref.) 0.89 (0.73–1.08) 0.88 (0.71–1.08) 0.84 (0.67–1.07) 0.110
 Model 2δ 1.00 (ref.) 0.92 (0.75–1.12) 0.89 (0.72–1.10) 0.86 (0.68–1.09) 0.160
 Model 3ε 1.00 (ref.) 0.93 (0.76–1.14) 0.91 (0.73–1.12) 0.87 (0.69–1.11) 0.221
Open in a new tab

αHazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated by Cox proportional hazards models

βP trend was calculated by treating exposure as a continuous variable

γModel 1 was adjusted for age (continuous)

δModel 2 was adjusted for Model 1 plus education level (junior high school or lower, high school, college or higher, or missing), BMI (< 18.5 kg/m2, 18.5–24.9 kg/m2, ≥ 25.0 kg/m2, or missing), smoking status (never, former, < 20 cigarettes/day, ≥ 20 cigarettes/day, or missing), alcohol drinking status (current, never, former, or missing), history of hypertension (yes, or no), and history of diabetes (yes, or no)

εModel 3 was adjusted for Model 2 plus energy intake (sex-specific tertiles or missing), fish intake (sex-specific tertiles or missing),and vegetable and fruit intake (sex-specific tertiles or missing)

Table 5.

Association between cheese intake and mortality (n = 34,161)α

Cheese intake frequency P trendβ
Almost never 1–2 times/mo 1–2 times/wk 3 times/wk/
Almost daily
Men
 Person-years 1,67,125 1,25,487 45,575 15,276
All-cause mortality
 No. of death 2276 1345 523 210
 Model 1γ 1.00 (ref.) 0.87 (0.81–0.93) 0.90 (0.82–1.00) 0.98 (0.85–1.13) 0.018
 Model 2δ 1.00 (ref.) 0.89 (0.83–0.95) 0.94 (0.85–1.03) 1.03 (0.89–1.18) 0.158
 Model 3ε 1.00 (ref.) 0.89 (0.83–0.96) 0.96 (0.87–1.05) 1.05 (0.91–1.22) 0.356
Cancer mortality
 No. of death 838 566 231 78
 Model 1γ 1.00 (ref.) 0.99 (0.89–1.11) 1.09 (0.94–1.26) 0.99 (0.79–1.25) 0.548
 Model 2δ 1.00 (ref.) 1.00 (0.90–1.12) 1.11 (0.96–1.29) 1.03 (0.81–1.30) 0.322
 Model 3ε 1.00 (ref.) 1.01 (0.91–1.13) 1.15 (0.99–1.33) 1.08 (0.85–1.36) 0.140
CVD mortality
 No. of death 573 309 115 51
 Model 1γ 1.00 (ref.) 0.80 (0.70–0.92) 0.79 (0.65–0.97) 0.95 (0.71–1.26) 0.017
 Model 2δ 1.00 (ref.) 0.82 (0.72–0.95) 0.86 (0.70–1.05) 1.00 (0.75–1.34) 0.114
 Model 3ε 1.00 (ref.) 0.83 (0.72–0.95) 0.86 (0.70–1.06) 1.01 (0.75–1.34) 0.136
Women
 Person-years 1,89,818 1,24,799 60,612 21,323
All-cause mortality
 No. of death 1385 685 324 128
 Model 1γ 1.00 (ref.) 0.86 (0.79–0.94) 0.84 (0.75–0.95) 0.85 (0.71–1.02) 0.001
 Model 2δ 1.00 (ref.) 0.89 (0.81–0.98) 0.88 (0.78–0.99) 0.89 (0.74–1.07) 0.013
 Model 3ε 1.00 (ref.) 0.89 (0.81–0.98) 0.88 (0.78–1.00) 0.89 (0.74–1.07) 0.016
Cancer mortality
 No. of death 437 236 122 44
 Model 1γ 1.00 (ref.) 0.92 (0.79–1.08) 0.98 (0.80–1.20) 0.92 (0.67–1.25) 0.536
 Model 2δ 1.00 (ref.) 0.95 (0.81–1.11) 1.02 (0.83–1.25) 0.95 (0.70–1.30) 0.819
 Model 3ε 1.00 (ref.) 0.96 (0.81–1.12) 1.03 (0.84–1.27) 0.95 (0.70–1.31) 0.923
CVD mortality
 No. of death 354 172 83 36
 Model 1γ 1.00 (ref.) 0.88 (0.73–1.05) 0.88 (0.69–1.12) 0.94 (0.67–1.33) 0.254
 Model 2δ 1.00 (ref.) 0.90 (0.75–1.09) 0.93 (0.73–1.18) 0.99 (0.70–1.40) 0.546
 Model 3ε 1.00 (ref.) 0.91 (0.76–1.10) 0.95 (0.74–1.21) 0.99 (0.70–1.41) 0.634
Open in a new tab

αHazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated by Cox proportional hazards models

βP trend was calculated by treating exposure as a continuous variable

γModel 1 was adjusted for age (continuous)

δModel 2 was adjusted for Model 1 plus education level (junior high school or lower, high school, college or higher, or missing), BMI (< 18.5 kg/m2, 18.5–24.9 kg/m2, ≥ 25.0 kg/m2, or missing), smoking status (never, former, < 20 cigarettes/day, ≥ 20 cigarettes/day, or missing), alcohol drinking status (current, never, former, or missing), history of hypertension (yes, or no), and history of diabetes (yes, or no)

εModel 3 was adjusted for Model 2 plus energy intake (sex-specific tertiles or missing), fish intake (sex-specific tertiles or missing),and vegetable and fruit intake (sex-specific tertiles or missing)

Sensitivity analyses

We conducted a sensitivity analysis by excluding deaths in the initial three years of follow-up, but the results were not essentially changed for total dairy intake and subgroup dairy products (e-Tables 3 and 4). We also conducted stratified analyses by age, BMI, and smoking status (e-Tables 5–8), and the results did not differ by those stratified variables. Moreover, we applied multiple imputation for missing values for dairy products and re-analyzed the imputed data, but the pattern of observed results remained for both total dairy intake and subgroup dairy products (e-Tables 9 and 10).

Discussion

Main findings

The present study examined the associations of both total dairy intake and subgroup dairy products with all-cause, cancer, and CVD mortality using a large-scale cohort study of the Japanese population with a follow-up period up to 25 years. The results suggested that dairy intake was not associated with mortality, except for limited evidence showing a modest association between cheese intake and a lower risk of all-cause mortality in Japanese women.

Comparisons with previous studies

There were no associations between total dairy intake and all-cause, cancer, and CVD mortality, which were in line with previous meta-analyses [16, 18, 24]. One suggested that total dairy products intake (per 200 g/day) was not associated with all-cancer mortality risk (RR: 0.99, 95% CI 0.96–1.03), but there was considerable heterogeneity (I2 = 62.2%, p = 0.005) [18]. The other study found that the highest group of total dairy intake was not associated with cancer mortality (RR: 0.99, 95% CI 0.92–1.07) compared to the lowest group [24]. Most cohort studies included in the meta-analyses were from Western populations, and no meta-analyses reported results stratified by study regions. We identified several cohort studies from Asia [26, 43–45]. One study from Japan showed that consumption of milk and dairy products (per 100 g/day) was inversely associated with CVD mortality risk in women (HR: 0.86, 95% CI 0.74–0.99), but not in men [26]. Studies from Taiwan (0 vs. > 7 times/week) and Iran (per serving/day; 230 g for milk and yogurt and 28 g for cheese) both suggested that total dairy intake was inversely associated with all-cause and CVD mortality, but not cancer mortality [43, 44], and the Iranian study also found that the association was more apparent for low-fat dairy intake [44]. Another study from Singapore suggested a marginally significant inverse association between total dairy intake and CVD mortality, especially stroke mortality, but only in men and those without a prior history of CVD [45].

Milk intake was not associated with all-cause, cancer, and CVD mortality in the present study. Numerous meta-analyses generally reported null associations [16, 18, 19, 21, 22, 24], but studies conducted in Asian populations showed controversial results [27, 44, 46, 47]. For all-cause mortality, four meta-analyses found no association with milk intake [18, 19, 21, 22], although three of them had considerable heterogeneity (I2: 72.3–97.4%) [18, 19, 22]. Two cohort studies from Iran and China suggested no association between milk and all-cause mortality [44, 46], whereas one Japanese study found that milk intake was associated with a lower risk only in men aged 65 years or older, but not in women [27]. An Iranian study suggested that consuming whole milk daily or more was associated with a higher risk of all-cause mortality compared to non-consumers, but they only included a small number of study participants [47]. For cancer mortality, one meta-analysis reported a null association with milk intake [24], which was also suggested in an Iranian study [44]. The Japanese study found that people drinking milk had a lower risk of cancer mortality only among men aged 65 years or older, but the association was not linear [27]. In contrast, the study from China reported that high milk consumption (> 3 servings/week; 1 serving = 250 ml) was associated with a higher cancer mortality risk [46], but the association between milk intake and cancer is rather complex considering the different effects on various site-specific cancers [48]. For CVD mortality, one meta-analysis suggested that there was no significant association with milk intake, but high heterogeneity was observed [21]. Several studies from Asian regions also did not find an increased risk of CVD mortality in people with higher milk intake [44, 46, 47]. The inconsistency in the milk–mortality association among previous studies may be attributable to different milk intake assessments (e.g., times/week, servings/day, or g/day) and amounts of milk intake, the inclusion of different confounders in the models, various follow-up periods, or variations in age and the number of study participants.

For yogurt intake, we did not find any associations with mortality in both men and women. The present study is the first to examine the association between yogurt intake and all-cause and CVD mortality in the Japanese population. Previous meta-analyses did not find yogurt to be associated with the risk of mortality [18, 24, 49], but one reported large heterogeneity (I2 = 65.8%, p = 0.054) across studies included [18]. One meta-analysis presented subgroup results according to study regions (4 studies from Europe and 2 studies from Asia), and no association was found for both regions [49]. One of the two Asian studies was from Iran and reported a modest inverse association between yogurt intake (per serving/day; 1 serving: 230 g) and all-cause and CVD mortality, but not cancer mortality [44], whereas the other from Japan only investigated the association with cancer mortality, and no association was found (daily vs. not daily) [25]. Several recent cohort studies did not show clear associations between yogurt intake and mortality risks in US and European adults [16, 28, 50, 51]. However, one multinational cohort study including both Western and Eastern populations suggested that yogurt consumption was inversely associated with all-cause mortality, although it was uncertain whether the observation was consistent across different regions [52].

The only modest association in the present study was observed between cheese intake and all-cause mortality in Japanese women. No other studies have examined the association between cheese intake and all-cause, cancer or CVD mortality in the Japanese population. Less evidence was available compared to other dairy products. Two meta-analyses both indicated that cheese intake had no association with all-cause mortality; one included 11 (RR for per 10 g/day: 0.99, 95% CI 0.96–1.01) and the other included 9 (RR for per 50 g/day: 1.03, 95% CI 0.99–1.07) cohort studies [18, 53], but one observed significant heterogeneity (I2:93.3%, p < 0.001) [18]. Several cohort studies were published recently, and three agreed that cheese intake was inversely associated with all-cause mortality [16, 44, 54], whereas two other studies suggested a null association [28, 50]. One meta-analysis examining the association between cheese intake and cancer mortality found no association, although the number of studies included was limited [24]. As for CVD mortality, previous studies agreed that the association between cheese intake and CVD mortality was null or modestly inverse [28, 39, 40, 50, 54, 55].

Possible mechanisms

The underlying mechanism between cheese intake and all-cause mortality remains unknown, but it is suggested that cheese is rich in numerous nutrients such as whey protein or vitamin K2. Whey protein may have beneficial effects on reducing cardiovascular risk factors, such as improving glucose levels, insulin response and lipid profile as well as lowering blood pressure and controlling body weight [56–58]. Vitamin K2, which is exclusively synthesized by bacteria and predominantly found in fermented foods like cheese, has been shown to plays an important role in preventing metabolic syndrome [59] and CVDs [60–62], although the relation between Vitamin K2 and mortality has shown inconsistency [60, 63, 64]. Moreover, prior studies found that probiotic bacteria in fermented dairy products were reported to have positive effects on immunity, inflammation, diarrhea prevention, and cardiovascular risk factors in clinical trials [3]. Fermented dairy product intake was also inversely associated with all-cause mortality [18, 38], but one study found a marginally inverse association with cheese, but not yogurt, by examining different types of fermented food in relation to all-cause mortality [18]. More speculatively, the lack of association with yogurt may be attributed to the fact that many yogurt products on the market have a certain amount of sugar added [1]. In addition, other than the isolated effect from individual nutrient, current evidence has indicated that the matrix effect of hard cheese may have benefits in reducing the amount of fat absorbed and lowering the blood cholesterol response [65, 66], ultimately leading to an improvement in cardiovascular health [67]. Nevertheless, the observed association between cheese intake and all-cause mortality in the present study could simply be a chance finding due to tests of multiple outcomes. It also needs caution that the correlation between dietary records and the FFQ of cheese was lower than that of milk or yogurt in the present study, which suggested a poorer validity of cheese intake possibly owing to the low intake amount in the study population. Thus, more studies are warranted to confirm the present observation.

Limitation and strengths

Our study has some strengths, including a large number of study participants, a long period of follow-up, and a high follow-up rate. Meanwhile, some limitations should also be mentioned. First, dairy intake was obtained from a self-reported FFQ, so the misclassification of exposure would be possible. Second, dairy intake was assessed only once, at baseline, but it may change over time during follow-up. Third, details of types of dairy products (e.g., high-fat or low-fat dairy products) were not obtained, and different types of dairy products may affect health diversely. Finally, although a considerable number of covariates were adjusted in our models, residual and unmeasured confounding may still have affected the results.

Conclusion

The results of the present study suggested that dairy intake was not associated with all-cause, cancer, and CVD mortality in Japanese adults, except for limited evidence showing a modest association between cheese intake and a lower risk of all-cause mortality in women.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 370 kb) (370.2KB, pdf)

Acknowledgements

Y.L. received financial support from the Otsuka Toshimi Scholarship on the period of 2019–2021.

Abbreviations

ANOVA

Analysis of variance

CHD

Coronary heart disease

CI

Confidence interval

CVD

Cardiovascular disease

FFQ

Food frequency questionnaire

HR

Hazard ratio

MI

Myocardial infarction

Author contributions

IT and AF designed and conducted research; YL analyzed data and wrote the paper; SM, YS, and IT provided constructive suggestions; YS had primary responsibility for final content. All authors read and approved the final manuscript.

Funding

This work was supported by a grant-in-aid from the Ministry of Health, Labour and Welfare, Health and Labor Sciences research grants, Japan (Comprehensive Research on Cardiovascular and Life-Style Related Diseases: 19FA2001, 20FA1002).

Availability of data and materials and code availability

Data described in the manuscript, code book, and analytic code will not be made publicly available because private information of participants were included but are available from the corresponding author on reasonable request.

Declarations

Conflict of interest

All authors declare that they have no conflict of interest.

References

  • 1.Cavero-Redondo I, Alvarez-Bueno C, Sotos-Prieto M, Gil A, Martinez-Vizcaino V, et al. Milk and dairy product consumption and risk of mortality: an overview of systematic reviews and meta-analyses. Adv Nutr. 2019;10(suppl_2):S97–S104. doi: 10.1093/advances/nmy128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Soedamah-Muthu SS, de Goede J. Dairy consumption and cardiometabolic diseases: systematic review and updated meta-analyses of prospective cohort studies. Curr Nutr Rep. 2018;7(4):171–182. doi: 10.1007/s13668-018-0253-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Yu E, Hu FB. Dairy products, dairy fatty acids, and the prevention of cardiometabolic disease: a review of recent evidence. Curr Atheroscler Rep. 2018;20(5):24. doi: 10.1007/s11883-018-0724-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kazemi A, Barati-Boldaji R, Soltani S, Mohammadipoor N, Esmaeilinezhad Z, et al. Intake of various food groups and risk of breast cancer: a systematic review and dose-response meta-analysis of prospective studies. Adv Nutr. 2021;12(3):809–849. doi: 10.1093/advances/nmaa147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World Cancer Research Fund/American Insititute for Cancer Research (2018) Continuous Update Project Expert Report 2018. Meat, fish and dairy products and the risk of cancer. https://www.wcrf.org/diet-and-cancer/
  • 6.Barrubes L, Babio N, Becerra-Tomas N, Rosique-Esteban N, Salas-Salvado J. Association between dairy product consumption and colorectal cancer risk in adults: a systematic review and meta-analysis of epidemiologic Studies. Adv Nutr. 2019;10(suppl_2):S190–S211. doi: 10.1093/advances/nmy114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Aljuraiban GS, Stamler J, Chan Q, Van Horn L, Daviglus ML, et al. Relations between dairy product intake and blood pressure: the INTERnational study on MAcro/micronutrients and blood Pressure. J Hypertens. 2018;36(10):2049–2058. doi: 10.1097/HJH.0000000000001779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Schmidt KA, Cromer G, Burhans MS, Kuzma JN, Hagman DK, et al. Impact of low-fat and full-fat dairy foods on fasting lipid profile and blood pressure: exploratory endpoints of a randomized controlled trial. Am J Clin Nutr. 2021;114(3):882–892. doi: 10.1093/ajcn/nqab131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rancourt-Bouchard M, Gigleux I, Guay V, Charest A, Saint-Gelais D, et al. Effects of regular-fat and low-fat dairy consumption on daytime ambulatory blood pressure and other cardiometabolic risk factors: a randomized controlled feeding trial. Am J Clin Nutr. 2020;111(1):42–51. doi: 10.1093/ajcn/nqz251. [DOI] [PubMed] [Google Scholar]
  • 10.Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, et al. Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2017;136(3):e1–e23. doi: 10.1161/CIR.0000000000000510. [DOI] [PubMed] [Google Scholar]
  • 11.Huth PJ, Park KM. Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence. Adv Nutr. 2012;3(3):266–285. doi: 10.3945/an.112.002030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lopez-Plaza B, Bermejo LM, Santurino C, Cavero-Redondo I, Alvarez-Bueno C, et al. Milk and dairy product consumption and prostate cancer risk and mortality: an overview of systematic reviews and meta-analyses. Adv Nutr. 2019;10(suppl_2):S212–S223. doi: 10.1093/advances/nmz014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Harrison S, Lennon R, Holly J, Higgins JPT, Gardner M, et al. Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis. Cancer Causes Control. 2017;28(6):497–528. doi: 10.1007/s10552-017-0883-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ganmaa D, Cui X, Feskanich D, Hankinson SE, Willett WC. Milk, dairy intake and risk of endometrial cancer: a 26-year follow-up. Int J Cancer. 2012;130(11):2664–2671. doi: 10.1002/ijc.26265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Willett WC, Ludwig DS. Milk and health. N Engl J Med. 2020;382(7):644–654. doi: 10.1056/NEJMra1903547. [DOI] [PubMed] [Google Scholar]
  • 16.Mazidi M, Mikhailidis DP, Sattar N, Howard G, Graham I, et al. Consumption of dairy product and its association with total and cause specific mortality—a population-based cohort study and meta-analysis. Clin Nutr. 2019;38(6):2833–2845. doi: 10.1016/j.clnu.2018.12.015. [DOI] [PubMed] [Google Scholar]
  • 17.Schwingshackl L, Schwedhelm C, Hoffmann G, Lampousi AM, Knuppel S, et al. Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2017;105(6):1462–1473. doi: 10.3945/ajcn.117.153148. [DOI] [PubMed] [Google Scholar]
  • 18.Guo J, Astrup A, Lovegrove JA, Gijsbers L, Givens DI, et al. Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2017;32(4):269–287. doi: 10.1007/s10654-017-0243-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mullie P, Pizot C, Autier P. Daily milk consumption and all-cause mortality, coronary heart disease and stroke: a systematic review and meta-analysis of observational cohort studies. BMC Public Health. 2016;16(1):1236. doi: 10.1186/s12889-016-3889-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Larsson SC, Crippa A, Orsini N, Wolk A, Michaelsson K. Milk consumption and mortality from all causes, cardiovascular disease, and cancer: a systematic review and meta-analysis. Nutrients. 2015;7(9):7749–7763. doi: 10.3390/nu7095363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.O'Sullivan TA, Hafekost K, Mitrou F, Lawrence D. Food sources of saturated fat and the association with mortality: a meta-analysis. Am J Public Health. 2013;103(9):e31–42. doi: 10.2105/AJPH.2013.301492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, Engberink MF, et al. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: dose-response meta-analysis of prospective cohort studies. Am J Clin Nutr. 2011;93(1):158–171. doi: 10.3945/ajcn.2010.29866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Elwood PC, Pickering JE, Givens DI, Gallacher JE. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids. 2010;45(10):925–939. doi: 10.1007/s11745-010-3412-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lu W, Chen H, Niu Y, Wu H, Xia D, et al. Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based cohort studies. Nutr J. 2016;15(1):91. doi: 10.1186/s12937-016-0210-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Matsumoto M, Ishikawa S, Nakamura Y, Kayaba K, Kajii E. Consumption of dairy products and cancer risks. J Epidemiol. 2007;17(2):38–44. doi: 10.2188/jea.17.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kondo I, Ojima T, Nakamura M, Hayasaka S, Hozawa A, et al. Consumption of dairy products and death from cardiovascular disease in the Japanese general population: the NIPPON DATA80. J Epidemiol. 2013;23(1):47–54. doi: 10.2188/jea.je20120054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Wang C, Yatsuya H, Tamakoshi K, Iso H, Tamakoshi A. Milk drinking and mortality: findings from the Japan collaborative cohort study. J Epidemiol. 2015;25(1):66–73. doi: 10.2188/jea.JE20140081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ding M, Li J, Qi L, Ellervik C, Zhang X, et al. Associations of dairy intake with risk of mortality in women and men: three prospective cohort studies. BMJ. 2019 doi: 10.1136/bmj.l6204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Tognon G, Nilsson LM, Shungin D, Lissner L, Jansson JH, et al. Nonfermented milk and other dairy products: associations with all-cause mortality. Am J Clin Nutr. 2017;105(6):1502–1511. doi: 10.3945/ajcn.116.140798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fukao A, Tsubono Y, Komatsu S, Tsuji I, Minami Y, et al. A cohort study on the relation of lifestyle, personality and biologic markers to cancer in Miyagi, Japan: study design, response rate and profiles of the cohort subjects. J Epidemiol. 1995;5(3):153–157. doi: 10.2188/jea.5.153. [DOI] [Google Scholar]
  • 31.Tsuji I, Nishino Y, Ohkubo T, Kuwahara A, Ogawa K, et al. A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol. 1998;8(5):258–263. doi: 10.2188/jea.8.258. [DOI] [PubMed] [Google Scholar]
  • 32.Ogawa K, Tsubono Y, Nishino Y, Watanabe Y, Ohkubo T, et al. Validation of a food-frequency questionnaire for cohort studies in rural Japan. Public Health Nutr. 2003;6(2):147–157. doi: 10.1079/PHN2002411. [DOI] [PubMed] [Google Scholar]
  • 33.Science and Technology Agency (1982) Standard Tables of Food Composition in Japan, 4th edn. Printing Bureau, Ministry of Finance, Tokyo
  • 34.Nakaya N, Tsubono Y, Hosokawa T, Nishino Y, Ohkubo T, et al. Personality and the risk of cancer. J Natl Cancer Inst. 2003;95(11):799–805. doi: 10.1093/jnci/95.11.799. [DOI] [PubMed] [Google Scholar]
  • 35.Nakaya N, Tsubono Y, Nishino Y, Hosokawa T, Fukudo S, et al. Personality and cancer survival: the Miyagi cohort study. Br J Cancer. 2005;92(11):2089–2094. doi: 10.1038/sj.bjc.6602610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Matsuyama S, Zhang S, Tomata Y, Abe S, Tanji F, et al. Association between improved adherence to the Japanese diet and incident functional disability in older people: The Ohsaki Cohort 2006 Study. Clin Nutr. 2020;39(7):2238–2245. doi: 10.1016/j.clnu.2019.10.008. [DOI] [PubMed] [Google Scholar]
  • 37.Ministry of Health, Labour and Welfare (1992) The National Health and Nutrition Survey in Japan, 1990. Daiichi Shuppan, Tokyo
  • 38.Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Br J Nutr. 2013;109(4):718–726. doi: 10.1017/S0007114512001845. [DOI] [PubMed] [Google Scholar]
  • 39.Bonthuis M, Hughes MC, Ibiebele TI, Green AC, van der Pols JC. Dairy consumption and patterns of mortality of Australian adults. Eur J Clin Nutr. 2010;64(6):569–577. doi: 10.1038/ejcn.2010.45. [DOI] [PubMed] [Google Scholar]
  • 40.van Aerde MA, Soedamah-Muthu SS, Geleijnse JM, Snijder MB, Nijpels G, et al. Dairy intake in relation to cardiovascular disease mortality and all-cause mortality: the Hoorn Study. Eur J Nutr. 2013;52(2):609–616. doi: 10.1007/s00394-012-0363-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Michaelsson K, Wolk A, Langenskiold S, Basu S, Warensjo Lemming E, et al. Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ. 2014 doi: 10.1136/bmj.g6015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Praagman J, Franco OH, Ikram MA, Soedamah-Muthu SS, Engberink MF, et al. Dairy products and the risk of stroke and coronary heart disease: the Rotterdam Study. Eur J Nutr. 2015;54(6):981–990. doi: 10.1007/s00394-014-0774-0. [DOI] [PubMed] [Google Scholar]
  • 43.Huang LY, Wahlqvist ML, Huang YC, Lee MS. Optimal dairy intake is predicated on total, cardiovascular, and stroke mortalities in a Taiwanese cohort. J Am Coll Nutr. 2014;33(6):426–436. doi: 10.1080/07315724.2013.875328. [DOI] [PubMed] [Google Scholar]
  • 44.Farvid MS, Malekshah AF, Pourshams A, Poustchi H, Sepanlou SG, et al. dairy food intake and all-cause, cardiovascular disease, and cancer mortality: The Golestan Cohort Study. Am J Epidemiol. 2017;185(8):697–711. doi: 10.1093/aje/kww139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Talaei M, Koh WP, Yuan JM, Pan A. The association between dairy product intake and cardiovascular disease mortality in Chinese adults. Eur J Nutr. 2017;56(7):2343–2352. doi: 10.1007/s00394-016-1274-1. [DOI] [PubMed] [Google Scholar]
  • 46.Wang XJ, Jiang CQ, Zhang WS, Zhu F, Jin YL, et al. Milk consumption and risk of mortality from all-cause, cardiovascular disease and cancer in older people. Clin Nutr. 2020;39(11):3442–3451. doi: 10.1016/j.clnu.2020.03.003. [DOI] [PubMed] [Google Scholar]
  • 47.Talaei M, Hosseini N, van Dam RM, Sadeghi M, Oveisgharan S, et al. Whole milk consumption and risk of cardiovascular disease and mortality: Isfahan Cohort Study. Eur J Nutr. 2019;58(1):163–171. doi: 10.1007/s00394-017-1581-1. [DOI] [PubMed] [Google Scholar]
  • 48.Jeyaraman MM, Abou-Setta AM, Grant L, Farshidfar F, Copstein L, et al. Dairy product consumption and development of cancer: an overview of reviews. BMJ Open. 2019;9(1):e023625. doi: 10.1136/bmjopen-2018-023625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gao X, Jia HY, Chen GC, Li CY, Hao M. Yogurt intake reduces all-cause and cardiovascular disease mortality: a meta-analysis of eight prospective cohort studies. Chin J Integr Med. 2020;26(6):462–468. doi: 10.1007/s11655-020-3085-8. [DOI] [PubMed] [Google Scholar]
  • 50.Pala V, Sieri S, Chiodini P, Masala G, Palli D, et al. Associations of dairy product consumption with mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Italy cohort. Am J Clin Nutr. 2019;110(5):1220–1230. doi: 10.1093/ajcn/nqz183. [DOI] [PubMed] [Google Scholar]
  • 51.Schmid D, Song M, Zhang X, Willett WC, Vaidya R, et al. Yogurt consumption in relation to mortality from cardiovascular disease, cancer, and all causes: a prospective investigation in 2 cohorts of US women and men. Am J Clin Nutr. 2020;111(3):689–697. doi: 10.1093/ajcn/nqz345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Dehghan M, Mente A, Rangarajan S, Sheridan P, Mohan V, et al. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2018;392(10161):2288–2297. doi: 10.1016/S0140-6736(18)31812-9. [DOI] [PubMed] [Google Scholar]
  • 53.Tong X, Chen GC, Zhang Z, Wei YL, Xu JY, et al. Cheese consumption and risk of all-cause mortality: a meta-analysis of prospective studies. Nutrients. 2017 doi: 10.3390/nu9010063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Tognon G, Rothenberg E, Petrolo M, Sundh V, Lissner L. Dairy product intake and mortality in a cohort of 70-year-old Swedes: a contribution to the Nordic diet discussion. Eur J Nutr. 2018;57(8):2869–2876. doi: 10.1007/s00394-017-1556-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Praagman J, Dalmeijer GW, van der Schouw YT, Soedamah-Muthu SS, Monique Verschuren WM, et al. The relationship between fermented food intake and mortality risk in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort. Br J Nutr. 2015;113(3):498–506. doi: 10.1017/S0007114514003766. [DOI] [PubMed] [Google Scholar]
  • 56.Pal S, Radavelli-Bagatini S. The effects of whey protein on cardiometabolic risk factors. Obesity Rev. 2013;14(4):324–343. doi: 10.1111/obr.12005. [DOI] [PubMed] [Google Scholar]
  • 57.Bjornshave A, Hermansen K. Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes. Rev Diabet Stud. 2014;11(2):153–166. doi: 10.1900/RDS.2014.11.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sousa GT, Lira FS, Rosa JC, de Oliveira EP, Oyama LM, et al. Dietary whey protein lessens several risk factors for metabolic diseases: a review. Lipids Health Dis. 2012 doi: 10.1186/1476-511X-11-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Dam V, Dalmeijer GW, Vermeer C, Drummen NE, Knapen MH, et al. Association between Vitamin K and the metabolic syndrome: a 10-year follow-up study in adults. J Clin Endocrinol Metab. 2015;100(6):2472–2479. doi: 10.1210/jc.2014-4449. [DOI] [PubMed] [Google Scholar]
  • 60.Chen HG, Sheng LT, Zhang YB, Cao AL, Lai YW, et al. Association of vitamin K with cardiovascular events and all-cause mortality: a systematic review and meta-analysis. Eur J Nutr. 2019;58(6):2191–2205. doi: 10.1007/s00394-019-01998-3. [DOI] [PubMed] [Google Scholar]
  • 61.Bellinge JW, Dalgaard F, Murray K, Connolly E, Blekkenhorst LC, et al. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study. J Am Heart Assoc. 2021;10(16):e020551. doi: 10.1161/JAHA.120.020551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134(11):3100–3105. doi: 10.1093/jn/134.11.3100. [DOI] [PubMed] [Google Scholar]
  • 63.Zwakenberg SR, den Braver NR, Engelen AIP, Feskens EJM, Vermeer C, et al. Vitamin K intake and all-cause and cause specific mortality. Clin Nutr. 2017;36(5):1294–1300. doi: 10.1016/j.clnu.2016.08.017. [DOI] [PubMed] [Google Scholar]
  • 64.Nimptsch K, Rohrmann S, Kaaks R, Linseisen J. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg) Am J Clin Nutr. 2010;91(5):1348–1358. doi: 10.3945/ajcn.2009.28691. [DOI] [PubMed] [Google Scholar]
  • 65.Thorning TK, Bertram HC, Bonjour JP, de Groot L, Dupont D, et al. Whole dairy matrix or single nutrients in assessment of health effects: current evidence and knowledge gaps. Am J Clin Nutr. 2017;105(5):1033–1045. doi: 10.3945/ajcn.116.151548. [DOI] [PubMed] [Google Scholar]
  • 66.Feeney EL, Barron R, Dible V, Hamilton Z, Power Y, et al. Dairy matrix effects: response to consumption of dairy fat differs when eaten within the cheese matrix-a randomized controlled trial. Am J Clin Nutr. 2018;108(4):667–674. doi: 10.1093/ajcn/nqy146. [DOI] [PubMed] [Google Scholar]
  • 67.Feeney EL, Lamichhane P, Sheehan JJ. The cheese matrix: Understanding the impact of cheese structure on aspects of cardiovascular health—a food science and a human nutrition perspective. Int J Dairy Technol. 2021 doi: 10.1111/1471-0307.12755. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary file1 (PDF 370 kb) (370.2KB, pdf)

Data Availability Statement

Data described in the manuscript, code book, and analytic code will not be made publicly available because private information of participants were included but are available from the corresponding author on reasonable request.

Articles from European Journal of Nutrition are provided here courtesy of Springer

RESOURCES